Loading clinical trials...
Loading clinical trials...
The goal of this clinical trial is to learn if the drug semaglutide works to reduce alcohol intake among adults living with HIV. The main questions it aims to answer are: 1. Does semaglutide lower th...
Bring this clarity to your next appointment.
Keep all your medical notes and next steps in one place.
Lead Sponsor
Vanderbilt University Medical Center
Collaborators
NCT01875588 · HIV Positive
NCT07027839 · Alcohol Use Disorder
NCT06002633 · Post-Traumatic Stress Disorder, Alcohol Drinking
NCT07265544 · Liver Neoplasm, HBV Infection, and more
NCT06857071 · Undiagnosed HIV Infection, Populations That Are Reluctant to Test for HIV, and more
Use Clareo to keep notes, questions, trial details, and next steps organized before and after appointments.
Start free trial →Data Source & Attribution
This clinical trial information is sourced from ClinicalTrials.gov, a service of the U.S. National Institutes of Health.
Modifications: This data has been reformatted for display purposes. Eligibility criteria have been parsed into inclusion/exclusion sections. Location data has been geocoded to enable distance-based search. For the authoritative and most current information, please visit ClinicalTrials.gov.
Neither the United States Government nor Clareo Health make any warranties regarding the data. Check ClinicalTrials.gov frequently for updates.
View ClinicalTrials.gov Terms and Conditions